Benjamin L Palleiko - Net Worth and Insider Trading
Benjamin L Palleiko Net Worth
The estimated net worth of Benjamin L Palleiko is at least $3 Million dollars as of 2024-11-29. Benjamin L Palleiko is the CHIEF EXECUTIVE OFFICER of KalVista Pharmaceuticals Inc and owns about 266,598 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $3 Million. Details can be seen in Benjamin L Palleiko's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Benjamin L Palleiko has not made any transactions after 2024-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Benjamin L Palleiko
Benjamin L Palleiko Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Benjamin L Palleiko owns 2 companies in total, including KalVista Pharmaceuticals Inc (KALV) , and Ore Holdings Inc (ORXE) .
Click here to see the complete history of Benjamin L Palleiko’s form 4 insider trades.
Insider Ownership Summary of Benjamin L Palleiko
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2024-11-18 | CFO and Secretary |
| ORXE | Ore Holdings Inc | 2010-01-18 | SVP & Chief Financial Officer |
Benjamin L Palleiko Latest Holdings Summary
Benjamin L Palleiko currently owns a total of 1 stock. Benjamin L Palleiko owns 266,598 shares of KalVista Pharmaceuticals Inc (KALV) as of November 18, 2024, with a value of $3 Million.
Latest Holdings of Benjamin L Palleiko
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2024-11-18 | 266,598 | 10.09 | 2,689,974 |
Holding Weightings of Benjamin L Palleiko
Benjamin L Palleiko Form 4 Trading Tracker
According to the SEC Form 4 filings, Benjamin L Palleiko has made a total of 15 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in KalVista Pharmaceuticals Inc is the sale of 14,400 shares on November 18, 2024, which brought Benjamin L Palleiko around $133,344.
Insider Trading History of Benjamin L Palleiko
- 1
Benjamin L Palleiko Trading Performance
Benjamin L Palleiko Ownership Network
Benjamin L Palleiko Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Benjamin L Palleiko is the CFO and Secretary of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include Chief Medical Officer Paul K. Audhya , Chief Development Officer Christopher Yea , and Chief Scientific Officer Edward P. Feener .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Benjamin L Palleiko made 9 insider transaction in KalVista Pharmaceuticals Inc (KALV) with a net sale of 155,123. Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 95,977 shares made by Christopher Yea , and a net sale of 63,847 shares made by Paul K. Audhya .
In summary, during the past 3 months, insiders sold 41,171 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 41,171 shares. During the past 18 months, 600,355 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 650,662 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
Benjamin L Palleiko Mailing Address
Above is the net worth, insider trading, and ownership report for Benjamin L Palleiko. You might contact Benjamin L Palleiko via mailing address: C/o Kalvista Pharmaceuticals, Inc., One Kendall Square, Bld 200, Ste 2203, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
